Pharmacokinetic dosing reduces aminoglycoside nephrotoxicity

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1381, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aminoglycoside Nephrotoxicity

Current Drug Targets - Infectious Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 153-162

Bentham Science Publishers

Access to resources Recommend Favorite

Aminoglycoside Dosages and Nephrotoxicity: Quantitative Relationships

By Rougier F.

Clinical Pharmacokinetics, Vol. 42, Iss. 5, 2003-01 ,pp. : 493-500

Adis International

Access to resources Recommend Favorite

Gender Differences in Aminoglycoside Induced Nephrotoxicity: A Prospective, Hospital - Based Study

Current Clinical Pharmacology, Vol. 4, Iss. 3, 2009-09 ,pp. : 229-232

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Considerations Relating to Tacrolimus Dosing in the Elderly

By Staatz Christine E. Tett Susan E.

Drugs & Aging, Vol. 22, Iss. 7, 2005-01 ,pp. : 541-557

Adis International

Access to resources Recommend Favorite

EFFECT OF DOSING VEHICLE ON THE HEPATOTOXICITY OF CCl4 AND NEPHROTOXICITY OF CHCl3 IN RATS

By Raymond Pierre Plaa Gabriel L.

Journal of Toxicology and Environmental Health, Vol. 51, Iss. 5, 1997-07 ,pp. : 463-476

Taylor & Francis Ltd

Access to resources Recommend Favorite